01:10 PM EST, 11/21/2025 (MT Newswires) -- Shuttle Pharmaceuticals ( SHPH ) said Friday it has finalized its purchase of Molecule.ai, a Canada-based artificial intelligence firm specializing in molecular discovery and drug development tools.

A Shuttle unit acquired nearly all of Molecule.ai's assets and liabilities for a total purchase price of $8 million payable in cash and shares, plus as much as $2 million in contingent payments tied to performance milestones, according to the company.

The company said an initial $3 million was paid at the completion of the deal, with the remaining consideration to be delivered over time through a mix of cash and stock.

Shuttle Pharmaceuticals ( SHPH ) shares fell over 9% in recent trading.

Price: 1.68, Change: -0.15, Percent Change: -8.20